Publication | Closed Access

Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol

Human Interleukin-12 GeneGliomaRecurrent Glioblastoma MultiformeImmunologyTumor ImmunityTherapeutic VaccineImmune SurveillanceImmunotherapeuticsImmunotherapyMedicineRadiation OncologyViral OncologyImmunogene TherapyCancer-associated Virus